{
  "Complete Blood Count (CBC)": "Leukopenia (low white blood cell count), anemia (low red blood cell count), and thrombocytopenia (low platelet count).",
  "Liver Function Tests (ALT, AST, Bilirubin)": "Elevated levels indicating hepatotoxicity or liver dysfunction.",
  "Renal Function Tests (Creatinine, BUN)": "Elevated creatinine and blood urea nitrogen (BUN) levels, indicating nephrotoxicity.",
  "Serum Electrolytes (Potassium, Magnesium, Sodium)": "Hyperkalemia (high potassium), hypomagnesemia (low magnesium), and hypernatremia (high sodium).",
  "Trough Tacrolimus Levels": "Abnormal therapeutic drug levels (too high or too low), impacting efficacy or toxicity.",
  "Blood Glucose": "Hyperglycemia, potentially leading to new-onset diabetes after transplantation (NODAT).",
  "Lipid Profile (Cholesterol, Triglycerides)": "Elevated levels, increasing cardiovascular risk.",
  "Urinalysis": "Proteinuria, hematuria, or casts indicating kidney involvement.",
  "Serum LDH": "Elevated levels in cases of hemolysis or tissue damage.",
  "C-Reactive Protein (CRP)": "Reduced levels due to immunosuppressive effects.",
  "Erythrocyte Sedimentation Rate (ESR)": "Reduced levels due to suppression of inflammatory responses.",
  "Direct Antiglobulin Test (DAT/Coombs Test)": "Positive in cases of drug-induced hemolytic anemia.",
  "Serum Uric Acid": "Elevated levels, potentially leading to gout.",
  "Bone Marrow Biopsy": "May show hypocellularity in cases of significant cytopenias.",
  "Serum Immunoglobulins (IgG, IgA, IgM)": "Reduced levels due to immunosuppressive effects.",
  "Parathyroid Hormone (PTH)": "Elevated levels, particularly in patients with chronic kidney disease.",
  "Pulmonary Function Tests (PFTs)": "Abnormal results if tacrolimus-induced pulmonary toxicity occurs."
}
